VEIL.AI was one of 15 startups selected from among 170 applicants for the Basel-based accelerator program DayOne Health 4.0, a six-month hybrid accelerator program for health tech startups interfacing with Pharma in the Basel area.
DayOne is based in Basel, the epicenter for pioneering health tech ventures in Switzerland. Their mission is to support startups and aid providers, corporations, and payers through external innovation. The DayOne accelerator began in 2018, is powered by global partners, and has catalyzed 87 international healthcare ventures in medtech and digital health through competitive, equity-free initiatives. The theme of this year’s accelerator is “Harnessing AI, data, and digital tools to power clinical development.
“The quality and diversity of the submissions for this year’s program were incredibly high, and I am excited to kick off the initial phase of the accelerator in September. All the companies in the cohort are bringing something of significant potential value to the healthtech space and I can’t wait to see how their journeys unfold.”
Cécile Tardy, Manager DayOne Health 4.0 Accelerator
VEIL.AI’s inclusion in this prestigious program underscores its pioneering work in the field of next-generation data anonymization. As the healthcare industry increasingly relies on data-driven insights, VEIL.AI’s technology plays a critical role in enabling the safe and effective use of sensitive information. Its solutions create high-quality, individual-level anonymized and synthetic data, allowing for multi-party data collaborations, re-use of legacy data, and the development of AI algorithms while staying compliant with the stringent regulations like the AI Act, GDPR, and EHDS. VEIL.AI’s capabilities align perfectly with DayOne’s topical theme of “Harnessing AI, data, and digital tools to power clinical development”, offering a unique value proposition that stands out within the cohort.
VEIL.AI will now begin Phase 1 of the acceleration program, fostering valuable connections with fellow startups, mentors, experts and accelerator program sponsors. By participating in this accelerator, VEIL.AI aims to further its mission of transforming the way sensitive health data is handled, ensuring that the benefits of data-driven innovation are realized without compromising patient privacy.
